OTLK Outlook Therapeutics, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Outlook Therapeutics (OTLK) Stock: Buy, Sell, or Hold?

$0.40
-0.02 (-4.04%) ▼
5d: -13.72% 30d: -18.82% 90d: -43.39%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$0.44 – $0.55
Position: OVERSOLD
Forward P/E & Valuation
-3.4x
Next 12M consensus est.
Wall Street Target
$5.03
+1116.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.41 / $0.50
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: OTLK is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When OTLK Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: OTLK is currently trading at $0.40, which is considered oversold relative to its 30-day fair value range of $0.44 to $0.55.

Technical Outlook: Technically, OTLK is in a strong downtrend. The price is currently testing key support at $0.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.

Market Sentiment: OTLK scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.03 (+1116.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.44 - $0.55
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $0.44 - $0.55
Current vs Trading Range OVERSOLD
Support Level $0.41
Resistance Level $0.50
Current Trend Strong Downtrend
Technical data as of Nov 13, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKDOWN
Days in Phase: 103d (53% conf)
30D Insider Cluster Signal CLUSTER BUY
30D Insider Buyers: 4 insiders ($2,599,996)
30D Net Insider Flow: +$2,599,996

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.0%)
  • BULLISH: Trading 1116.7% below Wall St target ($5.03)
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -3.44
Wall Street Target $5.03 (+1116.7%)
Revenue Growth (YoY) -99.4%
Share OTLK Analysis

Share this live OTLK analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (OTLK)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 16, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate a bullish sentiment towards $OTLK following the announcement of a price reduction for Lucentis, a competing drug. The OTLK team is expected to adjust their marketing strategy.
Key Retail Themes: Competition Marketing Strategy
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 1:53 PM ET
Data refreshes hourly during market hours. Next update: 2:53 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for OTLK.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 54 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 55 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 51 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 57 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
22 analysts
$107 42 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals